Advertisement

Combined immunoglobulin and plasmapheresis treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES)

      Abstract

      Febrile infection-related epilepsy syndrome (FIRES) is a rarely observed and destructive syndrome progressing with resistant seizures or refractory status epilepticus. In this report we present in a treatment procedure with plasmapheresis of a pediatric patient with FIRES and currently unknown etiology in order to contribute to the literature.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Transfusion and Apheresis Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hirsch L.J.
        • Gaspard N.
        • van Baalen A.
        • Nabbout R.
        • Demeret S.
        • Loddenkemper T.
        • et al.
        Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions.
        Epilepsia. 2018; 59: 739-744
        • Appenzeller S.
        • Helbig I.
        • Stephani U.
        • Haeusler M.
        • Kluger G.
        • Bungeroth M.
        • et al.
        Febrile infection‐related epilepsy syndrome (FIRES) is not caused by SCN1A, POLG,PCDH19 mutations or rare copy number variations.
        Dev Med Child Neurol. 2012; 54: 1144-1148
        • Van Baalen A.
        • Häusler M.
        • Boor R.
        • Rohr A.
        • Sperner J.
        • Kurlemann G.
        • et al.
        Febrile infection-related epilepsy syndrome (FIRES): a nonencephalitic encephalopathy in childhood.
        Epilepsia. 2010; 51: 1323-1328
        • Van Baalen A.
        • Häusler M.
        • Plecko-Startinig B.
        • Strautmanis J.
        • Vlaho S.
        • Gebhardt B.
        • et al.
        Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES.
        Neuropediatrics. 2012; 43: 209-216
        • Caraballo R.H.
        • Reyes G.
        • Avaria M.F.
        • Buompadre M.C.
        • Gonzalez M.
        • Fortini S.
        • et al.
        Febrile infection related epilepsy syndrome: a study of 12 patients.
        Seizure. 2013; 22: 553-559
        • Serino D.
        • Santarone M.E.
        • Caputo D.
        • Fusco L.
        Febrile infection-related epilepsy syndrome (FIRES): prevalence, impact and management strategies.
        Neuropsychiatr Dis Treat. 2019; 15: 1897-1903
        • Zeiler F.A.
        • Matuszczak M.
        • Teitelbaum J.
        • Kazina C.J.
        • Gillman L.M.
        Plasmapheresis for refractory status epilepticus Part II: a scoping systematic review of the pediatric literatüre.
        Seizure. 2016; 43: 61-68
        • Montgomery R.A.
        • Loupy A.
        • Segev D.L.
        Antibody‐mediated rejection: new approaches in prevention and management.
        Am J Transplant. 2018; 18: 3-17
        • Kesici S.
        • Tanyıldız M.
        • Yetimakman F.
        • Bayrakci B.
        A novel treatment strategy for severe Guillain-Barré syndrome: zipper method.
        J Child Neurol. 2019; 34: 277-283
      1. Baglan E. , Ozdel S. , Uysal Yazıcı M. , Azapağası E. , Çelik H. , Yüksel D. et al. , A novel therapeutic approach using the Zipper method to treat chorea in a pediatric-onset systemic lupus erythematosus patient. Lupus, 0961203320984013.